Page 8 - Revascularization Device News Today

Shares of Penumbra, Inc. (NYSE:PEN – Get Rating) have earned a consensus rating of “Buy” from the eleven research firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. […]

Penumbra - Consensus Indicates Potential 17.1% Upside